Tomaž Vovk

1.6k total citations
53 papers, 1.3k citations indexed

About

Tomaž Vovk is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Tomaž Vovk has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 9 papers in Molecular Biology and 9 papers in Psychiatry and Mental health. Recurrent topics in Tomaž Vovk's work include Pharmacological Effects and Toxicity Studies (11 papers), Epilepsy research and treatment (8 papers) and Analytical Methods in Pharmaceuticals (5 papers). Tomaž Vovk is often cited by papers focused on Pharmacological Effects and Toxicity Studies (11 papers), Epilepsy research and treatment (8 papers) and Analytical Methods in Pharmaceuticals (5 papers). Tomaž Vovk collaborates with scholars based in Slovenia, Italy and Serbia. Tomaž Vovk's co-authors include Iztok Grabnar, Boštjan Martinc, Blanka Kores Plesničar, Marija Bošković, Aleš Mrhar, Marija Bogataj, Jurij Trontelj, Robert Roškar, Vita Dolžan and David Drobne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Analytica Chimica Acta.

In The Last Decade

Tomaž Vovk

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomaž Vovk Slovenia 19 282 242 229 183 166 53 1.3k
Hualin Cai China 26 228 0.8× 106 0.4× 589 2.6× 203 1.1× 450 2.7× 106 1.9k
Sandra Orozco‐Suárez Mexico 26 444 1.6× 376 1.6× 470 2.1× 546 3.0× 59 0.4× 126 2.0k
Hugo Juárez Olguı́n Mexico 20 67 0.2× 157 0.6× 291 1.3× 157 0.9× 124 0.7× 134 1.3k
Noemí Cárdenas‐Rodríguez Mexico 20 197 0.7× 167 0.7× 555 2.4× 203 1.1× 61 0.4× 72 1.9k
Elżbieta Wyska Poland 26 242 0.9× 97 0.4× 671 2.9× 413 2.3× 227 1.4× 111 2.0k
Ai Tsuji Japan 21 102 0.4× 245 1.0× 608 2.7× 150 0.8× 110 0.7× 74 1.6k
Kiyoyuki Kitaichi Japan 32 167 0.6× 267 1.1× 848 3.7× 854 4.7× 183 1.1× 113 2.8k
Ritushree Kukreti India 25 317 1.1× 278 1.1× 464 2.0× 140 0.8× 49 0.3× 70 1.5k
Allan Weimann Denmark 28 191 0.7× 109 0.5× 1.2k 5.1× 48 0.3× 240 1.4× 75 2.6k
Mads Kreilgaard Denmark 19 123 0.4× 119 0.5× 339 1.5× 316 1.7× 65 0.4× 49 1.9k

Countries citing papers authored by Tomaž Vovk

Since Specialization
Citations

This map shows the geographic impact of Tomaž Vovk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomaž Vovk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomaž Vovk more than expected).

Fields of papers citing papers by Tomaž Vovk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomaž Vovk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomaž Vovk. The network helps show where Tomaž Vovk may publish in the future.

Co-authorship network of co-authors of Tomaž Vovk

This figure shows the co-authorship network connecting the top 25 collaborators of Tomaž Vovk. A scholar is included among the top collaborators of Tomaž Vovk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomaž Vovk. Tomaž Vovk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Locatelli, Igor, et al.. (2024). Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis. Redox Biology. 77. 103380–103380. 27 indexed citations
4.
5.
Petrič, Aleksandra Domanjko, Ana Nemec, Vida Rezar, et al.. (2023). Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1. Frontiers in Veterinary Science. 10. 1203480–1203480. 3 indexed citations
6.
Mandrioli, Roberto, Roccaldo Sardella, Tomaž Vovk, et al.. (2023). Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine. Journal of Pharmaceutical and Biomedical Analysis. 236. 115740–115740. 7 indexed citations
7.
8.
9.
Marolt, Gregor, et al.. (2022). Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors. Cancer Chemotherapy and Pharmacology. 90(4). 301–313. 3 indexed citations
10.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2021). Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model. Pharmaceutics. 13(10). 1587–1587. 17 indexed citations
11.
Protti, Michele, et al.. (2021). VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 195. 113873–113873. 19 indexed citations
12.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2020). Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission. Clinical Gastroenterology and Hepatology. 19(1). 111–118.e10. 32 indexed citations
13.
Svete, Alenka Nemec, Ana Nemec, Aleksandra Domanjko Petrič, et al.. (2020). Antioxidant capacity of lipid- and water-soluble antioxidants in dogs with subclinical myxomatous mitral valve degeneration anaesthetised with propofol or sevoflurane. BMC Veterinary Research. 16(1). 305–305. 4 indexed citations
14.
15.
Horvat, Nejc, Mitja Kos, Aleš Obreza, et al.. (2017). Curriculum Mapping of the Master’s Program in Pharmacy in Slovenia with the PHAR-QA Competency Framework. SHILAP Revista de lepidopterología. 5(2). 24–24. 5 indexed citations
16.
Grabnar, Iztok, et al.. (2015). Febrile neutropenia in chemotherapy treated small-cell lung cancer patients. Radiology and Oncology. 49(2). 173–180. 9 indexed citations
17.
Grabnar, Iztok, et al.. (2015). Dried blood spots for monitoring and individualization of antiepileptic drug treatment. European Journal of Pharmaceutical Sciences. 75. 25–39. 48 indexed citations
18.
19.
Martinc, Boštjan, Iztok Grabnar, & Tomaž Vovk. (2012). The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress. Current Neuropharmacology. 10(4). 328–343. 79 indexed citations
20.
Grabnar, Iztok, Tomaž Vovk, Blanka Kores Plesničar, & Marija Bošković. (2011). Oxidative Stress in Schizophrenia. Current Neuropharmacology. 9(2). 301–312. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hualin Cai Breakdown of academic impact, for papers by Sandra Orozco‐Suárez Breakdown of academic impact, for papers by Hugo Juárez Olguı́n Breakdown of academic impact, for papers by Noemí Cárdenas‐Rodríguez Breakdown of academic impact, for papers by Elżbieta Wyska Breakdown of academic impact, for papers by Ai Tsuji Breakdown of academic impact, for papers by Kiyoyuki Kitaichi Breakdown of academic impact, for papers by Ritushree Kukreti Breakdown of academic impact, for papers by Allan Weimann Breakdown of academic impact, for papers by Mads Kreilgaard
Rankless by CCL
2026